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We prospectively examined the relation between pretrial serum vitamin D status and risk of oesophageal and gastric cancers among
subjects who developed cancer over 5.25 years of follow-up, including 545 oesophageal squamous cell carcinomas (ESCC), 353
gastric cardia adenocarcinomas, 81 gastric noncardia adenocarcinomas, and an age- and sex-stratified random sample of 1105
subjects. The distribution of serum 25(OH)D was calculated using the known sampling weights. For the cohort as a whole, the 25th,
50th, and 75th percentile concentrations of 25(OH)-vitamin D were 19.6, 31.9, and 48.7nmoll
 1, respectively, and we found that
higher serum 25(OH)D concentrations were associated with monotonically increasing risk of ESCC in men, but not in women.
Comparing men in the fourth quartile of serum 25(OH)D concentrations to those in the first, we found a hazard ratio (HR) (95%
confidence interval (CI)) of 1.77 (1.16–2.70), P trend¼0.0033. The same comparison in women had a HR (95% CI) of 1.06
(0.71–1.59), P trend¼0.70. We found no associations for gastric cardia or noncardia adenocarcinoma. Among subjects with low
vitamin D status, higher serum 25(OH)D concentrations were associated with significantly increased risk of ESCC in men, but not in
women. Further refinements of the analysis did not suggest any factors, which could explain this unexpected result.
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Exposure of the skin to type-B ultraviolet radiation leads to the
production of vitamin D. Fortified dairy products, eggs, fish, liver,
and some plant foods also provide vitamin D. Three studies that
used different methods for estimating vitamin D exposure showed
that conditions that should favour higher vitamin D status were
associated with lower risk of oesophageal or stomach cancer.
Specifically, higher potential solar radiation in lower latitudes (Grant,
2002), higher vitamin D intake (Launoy et al, 1998), and higher
vitamin D exposure index (Giovannucci et al, 2006) were associated
with reduced risk of oesophageal and/or stomach cancer. One
hypothesis for this protection is that vitamin D can suppress diet-
induced epithelial cell hyperproliferation (Xue et al, 1999).
Vitamin D status can be assessed directly using serum 25-
hydroxy vitamin D (25(OH)-D) concentration, the best indicator of
status (Zittermann, 2003). While not the active form, it can be
converted into the active 1,25(OH)2 vitamin D in the kidney and at
other sites. It is not known whether the oesophagus or stomach
expresses the 25(OH)D-1a-hydroxylase enzyme that is necessary
for extrarenal activation (Townsend et al, 2005).
Linxian, a semi-arid mountainous area in central China (361 N
latitude), has a mainly rural population with some of the highest rates
of oesophageal squamous cell carcinoma (ESCC) and gastric cardia
adenocarcinoma in the world, with age-standardised rates for both
men and women of about 100/100000 year
 1 for the two tumours
combined (Ke, 2002). Prospective studies in Linxian showed
increased risk of these cancers in subjects with lower concentrations
of serum selenium (Mark et al, 2000), serum a-tocopherol (Taylor
et al,2 0 0 3 ) ,a n dt i s s u ez i n c( A b n e tet al, 2005). Deficiencies of b-
carotene, b-cryptoxanthin, and retinol are common but not
associated with increased risk of these tumours (Abnet et al, 2003).
No previous reports on vitamin D status exist for Linxian where the
traditional diet provides little vitamin D because fatty fish and liver
are taken sparingly (Zou et al, 2002), median egg intake was only 10
per year (Tran et al, 2004), and fortified products are not available.
In the current study, we have examined the relation
between serum 25(OH)D and the risk of ESCC, gastric cardia
adenocarcinomas, and gastric noncardia adenocarcinoma in a
large population-based cohort of subjects.
METHODS
Cohort population
Subjects were selected from the cohort of all participants in the
General Population Trial of Linxian. Elsewhere we have described
in detail the design, choice of intervention agents, methods of
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1993; Li et al, 1993). In brief, the participants were 29584 healthy
adults aged 40–69 years from four Linxian communes. In the
spring of 1985, 1 year before the start of the intervention, each
participant was interviewed, given a brief physical examination,
and had 10ml of blood drawn. Blood was stored on ice for 3–6h
during transport to the field station. The serum was separated by
centrifugation, then aliquoted, and immediately stored at  451C
for 3–4 days. The serum was stored at  851C for long-term
storage after transport to Beijing on dry ice and was not thawed
until used in the vitamin D assays. Intervention began in March
1986 and continued through May 1991. Subjects who died or
developed cancer in the interval between recruitment and the start
of the intervention were excluded from the trial and this cohort.
In accord with a partial factorial design, the participants were
randomly assigned to receive either a vitamin–mineral combina-
tion or a placebo. Vitamin D was not included in the General
Population Trial as an intervention agent. Village doctors
ascertained mortality among trial participants through monthly
follow-up; loss to follow-up was essentially zero. Cancers were
ascertained through local commune and county hospitals,
supplemented by a study team that provided clinical and
diagnostic services, including endoscopy, for patients with
symptoms suggestive of oesophageal or gastric cancer. A panel
of US and Chinese experts reviewed the diagnostic material for
85% of the cancer cases in this study. All oesophageal cancers were
squamous cell carcinomas. There were no adenocarcinomas in
the oesophagus in this study so we did not need to separate
oesophageal adenocarcinomas from gastric cardia cancers. For
anatomic localisation of gastric adenocarcinomas, we defined
cardia cancers as those located in the most proximal 3cm of the
stomach and non-cardia gastric cancers were those that originated
distal to this region. Ninety-five percent of the anatomic
localisations were made with the use of endoscopy, surgery, and/
or x-rays. For cancer cases without diagnostic materials and for
deaths due to causes other than cancer, senior Chinese diagnos-
ticians conducted reviews. We obtained informed consent from
each participant before trial enrollment. Throughout the study,
human subject protection procedures were approved by the
Institutional Review Boards of the U.S. National Institutes of
Health and the Chinese Academy of Medical Sciences.
Selection of study participants for serum measurements
We used a stratified case–cohort design (Prentice, 1986; Self and
Prentice, 1988) to select individuals for serum measurements from
the cohort of all participants in the General Population Trial. By
the end of the trial, there were 640 incident ESCC, 435 incident
gastric cardia adenocarcinomas, and 104 gastric non-cardia
adenocarcinomas (Blot et al, 1993). Overall, 83% of the case
subjects had adequate serum and a successful measurement of serum
vitamin D (545 oesophageal, 353 gastric cardia, and 81 gastric non-
cardia cancer subjects). In addition, we measured serum concentra-
tions in a stratified random sample of all trial participants, without
regard to outcome, as the comparison group (referred to as the
subcohort). The six strata were defined by sex and the following
three age categories at the start of intervention: (1) 50 years old or
younger, (2) older than 50–60 years old, and (3) older than 60 years.
A sufficient number of cohort subjects were drawn from each
stratum to achieve a ratio greater than 1:1 of control subjects to case
subjects for incident oesophageal and gastric cardia cancers
combined. Overall, we measured serum 25(OH)D concentration on
1105 subcohort subjects and 979 case subjects.
Laboratory analysis
Serum 25(OH)D concentrations were determined using OCTEIA
25-hydroxy Vitamin D enzyme immunoassay (IDS Inc., Fountain
Hills, AZ, USA) in the nutrition laboratory of the Cancer Institute,
Chinese Academy of Medical Sciences. This assay has been shown
to be accurate and reliable by the International Vitamin D Quality
Assessment Scheme (www.deqas.org), although it may slightly
overestimate serum 25(OH)D concentrations when they are in the
high range (Carter et al, 2004). The samples were analysed in a
sequence designed to minimise the possible bias in the estimation
of cancer risk that could be introduced if serum measurements
varied by time. Within every group of 10 samples, a sample from a
case subject was always accompanied by a sample from a control
subject from the same sex and age stratum. Case subjects with each
of the three cancer types in each of the six strata were mixed
throughout. For assessment of assay reliability, each plate had
one quality control sample of pooled serum and two control serum
samples, one with a high concentration and one with a low
concentration. Laboratory personnel were blind to the identity of
all samples. A total of 174 blinded assay reliability specimens were
measured. Coefficients of variation for the pooled serum sample,
high control, and low control were 16, 7, and 11%, respectively.
The methods used to assay serum selenium, a-tocopherol, retinol,
and cholesterol measurements have been described previously
(Mark et al, 2000; Abnet et al, 2003; Taylor et al, 2003).
Statistical analysis
To examine graphically the shape of the serum 25(OH)D
distributions, we used histograms and quantile–quantile plots
and found that the distribution was skewed. Log transformation
improved normality. All estimates of means were made using the
log-transformed values. In the tables we report log means returned
to the arithmetic scale, that is geometric means. Throughout the
paper, all P-values we report are from two-sided tests and an
a p0.05 was considered statistically significant.
The mean values and quantiles were calculated using the known
sampling weights from the entire General Population Trial cohort
for each individual in the study. Thus, the means and quantiles for
the serum 25(OH)D concentrations given for the subcohort in
Table 2 are estimates of the means and quantiles of the entire
General Population Trial cohort and not, as is generally the case,
the means and quantiles of those who never develop the cancers
under study. We tested for serum 25(OH)D concentration
differences between groups using the Wilcoxon rank–sum test.
We measured the time to cancer as time since March 1986 (start
of the intervention), as opposed to time since blood collection.
Individuals who died or developed cancer in this 1-year interval
were excluded from the General Population Trial and this analysis.
When analyzing cancers at a specific site we treated persons with
cancers at other sites as censored at the time of cancer occurrence.
We estimated hazard ratios (HR) and 95% confidence intervals
(CI) using the case–cohort estimator for the Cox proportional
hazards models available in the EPICURE software package
(Hirosoft International Corp., Seattle, WA, USA). All estimates
came from models stratified on the six sex–age sampling strata.
Additional stratum-specific age terms for continuous age were
used to adjust for variation within age stratum. Although they did
not materially alter the risk estimates, we retained tobacco
smoking and alcohol drinking in the models because they were
specified as potential confounders a priori. Body mass index was
tested and found not to alter risk estimates and was dropped from
the final models. Nested models were compared and P-values
calculated using score tests. To examine the proportionality
assumption, we used models that allowed time-dependent relative
risks and found no suggestion that HRs varied with time. We also
deleted the first 2 years of follow-up and found similar HRs to the
estimates using the full follow-up time.
We examined three different metrics for serum 25(OH)D
concentration: (1) as a continuous variable with the units
standardised to 15nmoll
 1, (2) as quartiles based on the
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assigned the ordinal quartile value as their exposure. We used sex-
specific quartile cutpoints in the sex-stratified analyses. We tested
for and found a statistically significant interaction for the
association between serum 25(OH)D concentration and risk of
ESCC by sex using the product of the sex and continuous serum
25(OH)D concentration. We found no significant interaction by
sex for either gastric cancer subsite. But, for comparison we
present estimates stratified by sex at each site. We found no
statistically significant interactions by age, serum selenium
concentration, or serum retinol concentration using either
continuous or categorical constructs for the interacting variables.
We tested for deviations from log linearity by adding quadratic
terms to the continuous models and by adding separate
parameters for individuals in the lowest and highest deciles
(threshold effects). No statistically significant quadratic deviations
or thresholds were found. We performed a sensitivity analysis to test
for outliers or influential points in the continuous main-effect HRs
by deleting the upper and lower 1% of serum values and there were
no substantial changes in relative-risk estimates. Finally, we tested
for a difference in the slope of the linear variable above and below
the level of adequacy (40nmoll
 1) using an interaction between the
continuous serum concentration and an adequacy indicator variable.
There was no evidence of deviations from linearity in the association
between serum concentrations and risk of cancer.
RESULTS
Table 1 presents the characteristics of the randomly selected
subcohort and the cancer cases overall and by sex. A total of 70%
men smoke lightly and drink little or no alcohol, and among
women, smoking was almost completely absent and alcohol
consumption was also low.
Table 2 presents the serum 25(OH)D geometric means and
quantiles in the population overall and stratified by sex, smoking
and drinking. Women had slightly lower serum 25(OH)D
concentrations than men. Men in the youngest age strata had
lower serum concentrations than older men, but there were no
clear age differences in women. Although the geometric means in
men never and ever smokers were not significantly different
(Wilcoxon rank–sum P¼0.13), smokers had a narrower distribu-
tion that led to a higher concentration at the 10th percentile and a
lower concentration at the 90th percentile. Men who drank any
alcohol in the past 12 months had lower serum 25(OH)D at each
quantile compared to men who did not drink any alcohol, but the
overall distributions were not significantly different (Wilcoxon
rank—sum, P¼0.40). It should be noted that using this construct,
any alcohol drinking in the previous 12 months is associated with a
non-significantly decreased risk of ESCC in this population (Tran
et al, 2004). Overall, serum 25(OH)D concentrations were higher
in subjects who developed each of the cancers compared to the
subcohort (Table 2). When examined separately by sex, the biggest
difference was for men who developed ESCC. The geometric
mean 25(OH)D concentration for the men in the subcohort
was 33.3nmoll
 1 and for men who developed ESCC it was
40.1nmoll
 1.
We present the multivariate adjusted HRs and 95% CIs for the
association between serum 25(OH)D concentration and cancer risk
in Table 3. We found a significant association with ESCC, but no
significant association for either gastric cancer site. We also found
a significant interaction between serum 25(OH)D and sex in the
association with ESCC (interaction P¼0.0065), the association
between serum 25(OH)D concentration and risk of ESCC only
being evident in men. In men we found a clear monotonically
increasing risk of ESCC, and subjects in the fourth quartile
had a 77% higher risk of ESCC than subjects in the lowest
quartile (HR (95% CI)¼1.77 (1.16–2.70)). This significant
association was present for the continuous variable, for the
quartiles, and for the quartile trend test. For ESCC in men, and
using cut points of (o40, 40–75, 75þ) we found that compared to
subjects with serum 25(OH)D of less than 40nmoll
 1 subjects in
the middle and upper category were associated with increased
risk of cancer with HR (95% CI) of 1.15 (0.82–1.61) and 2.01
(1.33–3.05), respectively.
To characterise better the association between serum 25(OH)D
concentration and risk of ESCC in men, we tested for deviations
from linearity using several methods and found no evidence of
nonlinearity. We split the cohort at the concentration of adequacy,
40nmoll
 1 and found no evidence of a difference in the slope of
the continuous variable below and above 40nmoll
 1 (P¼0.47),
and the continuous estimates were similar. Below 40nmoll
 1 the
HR (95% CI) for continuous vitamin D scaled to 15nmoll
 1 was
1.27 (0.97–1.66), and above 40nmoll
 1 it was 1.18 (1.07–1.30).
Finally, we explored several other potentially confounding
variables. We separately added variables for body mass index
(BMI), serum selenium, cholesterol and retinol, and cholesterol
and a-tocopherol and found that the serum 25(OH)D associations
were independent of these exposures and that there was no
evidence of interaction (data not shown).
Table 1 Nutrition intervention trial case–cohort subject characteristics by case status
Variable Subcohort
a ESCC Gastric cardia Gastric noncardia
Total no. 1105 545 353 81
Men, N (%) 610 (55%) 261 (48%) 204 (58%) 60 (74%)
Women, N (%) 495 (45%) 284 (52%) 149 (42%) 21 (26%)
Age, mean (s.d.) 56.6 (7.9) 56.4 (8.1) 57.1 (7.1) 58.5 (7.2)
Men, mean (s.d.) 57.7 (7.4) 57.4 (7.6) 57.8 (6.9) 59.7 (6.7)
Women, mean (s.d.) 55.3 (8.3) 55.4 (8.5) 56.1 (7.3) 55.1 (7.8)
Smoke, N (%) yes 427 (39%) 204 (37%) 144 (41%) 41 (51%)
Men, N (%) yes 425 (70%) 204 (78%) 144 (71%) 41 (68%)
Women, N (%) yes 2 (0.4%) 0 (0%) 0 (0%) 0 (0%)
Drink, N (%) yes 230 (21%) 123 (23%) 77 (22%) 20 (25%)
Men, N (%) yes 201 (33%) 105 (40%) 64 (31%) 19 (31%)
Women, N (%) yes 29 (6%) 18 (6%) 13 (9%) 1 (5%)
aSome subjects who later developed one of these cancers are included in the randomly selected subcohort. Therefore, the total number of subjects in this table is greater than
the 2018 with measured serum 25(OH)D concentrations.
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Contrary to previous reports, which examined indirect measures of
vitamin D status (Launoy et al, 1998; Grant, 2002; Giovannucci
et al, 2006), we found that higher serum 25(OH)D concentration
was associated with increased risk of ESCC, but not with cardia or
noncardia gastric cancer. This increased risk of ESCC appeared to
vary directly with increasing serum concentrations and there was
no evidence of thresholds or deviations from linearity. The
association was strong in men and absent in women. Unlike low
risk areas for ESCC where this disease is much more common in
men than in women, in Linxian the incidence rates are only slightly
lower in women than in men and sex is not a risk factor for this
disease in our cohort (Tran et al, 2004). We have previously found
little evidence of differences in risk factors for ESCC between men
and women in our cohort. Our previous findings that higher serum
concentrations of selenium (Mark et al, 2000) and a-tocopherol
(Taylor et al, 2003) were associated with lower risk of ESCC and
gastric cardia adenocarcinoma did not differ by sex.
Previous reports that vitamin D was associated with reduced
risk of oesophageal cancer did not use serum 25(OH)D to assess
status. A French case–control study used estimated dietary
vitamin D and found an OR of 0.70 for ESCC for subjects in the
highest quartile of estimated vitamin D intake compared to those
in the lowest (Launoy et al, 1998). This method does not account
for UVB generated vitamin D, the primary vitamin D source for
most people. An ecologic study of UVB radiation and oesophageal
and stomach cancer in the United States found negative
correlations of similar magnitude between UVB exposure and
oesophageal or stomach cancer rates (Grant, 2002). This study is
subject to all the limitations attendant to ecologic studies. Finally, a
third study used predicted vitamin D status based on individual
subject’s race, geographic region of residence, estimated dietary
vitamin D, BMI, and physical activity that had r
2¼0.28 with
measured serum 25(OH)D concentration (Giovannucci et al,
2006). This study from the United States reported significant RR
(95%, CI) of 0.37 (0.17–0.80) and 0.58 (0.26–1.33) for oesophageal
and stomach cancer, respectively, for a 25nmoll
 1 increase in
predicted serum 25(OH)D status. These authors did not distin-
guish between ESCC and oesophageal adenocarcinoma, but this
seems unlikely to explain the difference between their results and
ours since they reported lower risk of most digestive tract cancers
regardless of histology.
We note that two previous reports showed that higher measured
serum 25(OH)D concentrations are associated with increased
cancer risk in men. In a cohort of men from Nordic countries, a
U-shaped association for prostate cancer was shown, such that
a serum 25(OH)D concentration X80nmoll
 1 was associated with
at 70% higher risk of prostate cancer than with a concentration
between 40 and 59nmoll
 1 (Tuohimaa et al, 2004). In that cohort,
men with serum concentrations p19nmoll
 1 were at non-
significantly higher risk than those in the reference range. Second,
an increasing risk of pancreatic cancer was found with increasing
serum 25(OH)D concentration in the all male ATBC cohort
from Finland (Stolzenberg–Solomon et al, 2006). Men with a
serum concentration 465.5nmoll
 1 were at threefold higher
risk of pancreatic cancer than men with a serum concentration
o32nmoll
 1. All three studies showing higher risk of cancer
associated with higher serum vitamin D status found this
association in men. One was restricted to men because it was
prostate cancer, one because it was only studied in men, and ours
because the association was restricted to men. No simple rationale
for a difference in the association by sex is evident and whether
there is a consistent difference will require future studies. At least
one study found a significant protective effect of higher serum
25(OH)D concentration on risk of colorectal cancer in women
(Feskanich et al, 2004).
Both of the previous studies, which showed higher risk of cancer
with higher serum 25(OH)D concentration, were in Nordic
countries that, like our population have relatively low population
mean serum 25(OH)D concentrations. Our blood samples were
drawn in March when the population mean was probably at or
near its nadir, which may not reflect population rank at other
times of the year. About 60% of our population had a serum
25(OH)D concentration o40nmoll
 1 and nearly the entire cohort
was below 80nmoll
 1, the concentration that may be necessary to
maintain optimal calcium homoeostasis (Zittermann, 2003). The
mean serum concentration in US white males in the NHANES III
study was 83nmoll
 1 (Zadshir et al, 2005), but this was not
corrected for season and probably represents an average of
samples collected throughout the year. We cannot speculate on the
association between serum 25(OH)D concentration and risk of
ESCC or gastric cancer at the higher serum concentrations seen in
the United States and many other countries and it is possible that
subjects in the normal to high range of serum vitamin D values
may show differences.
An association between higher serum 25(OH)D concentration
and increased risk of prostate cancer could be due to the
correlation with higher retinol status, which may have adverse
effects on prostate cancer (Tuohimaa et al, 2004). Our population
generally has low serum concentrations of both nutrients, retinol
is not associated with ESCC risk in our cohort (Abnet et al,
2003), and controlling for serum retinol did not affect the
hazard estimates for serum 25(OH)D concentration. One
proposed mechanism of vitamin D cancer prevention is that it
suppresses high-fat diet induced epithelial cell hyperproliferation
Table 2 Serum 25(OH)D3 concentration geometric means (nmoll
 1)
and selected quantiles overall and by sex in the NIT General Population
Trial cohort and in cancer cases
Quantile
N
Geometric
mean
a 25th 50th 75th
NIT General Population Trial Cohort
b
Overall 2018 31.7 19.6 31.9 48.7
Men, overall 1090 33.5 20.3 33.6 51.6
Age strata 1 (40–50) 170 29.5 18.4 30.4 43.7
Age strata 2 (450–60) 497 36.7 24.2 38.5 59.2
Age strata 3 (460–70) 423 37.1 23.3 37.5 58.2
Never smokers 309 33.6 19.5 36.1 60.3
Ever smokers
c 781 33.4 21.2 32.9 48.9
Non-drinkers 717 34.7 21.4 35.7 53.7
Drinkers
d 373 31.2 18.6 32.2 47.4
Women
e, overall 928 30.4 18.7 30.7 45.9
Age strata 1 (40–50) 244 31.9 20.1 31.7 47.3
Age strata 2 (450–60) 402 27.9 17.7 28.7 42.2
Age strata 3 (460–70) 282 31.5 19.6 28.9 50.6
Cancer cases
ESCC 545 33.7 19.9 33.4 57.2
Gastric cardia adenocarcinoma 353 33.6 19.2 33.8 54.5
Gastric noncardia adenocarcinoma 81 33.5 19.1 37.5 56.1
Abbreviation: ESCC¼oesophageal squamous cell carcinomas.
aSerum vitamin D
distributions were skewed and normality was improved by log transformation, so
geometric means are presented.
bAll concentrations are weighted by the age and sex
sampling to reflect the distributions in the full cohort.
cDaily cigarette consumption
among men was generally low and few subjects had quit smoking, so smoking is
presented as never smoking vs ever smoking.
dAlcohol consumption was minimal at
the time of the baseline interview (1985), so alcohol drinking was categorized as any
consumption in the previous 12 months vs none.
eCigarette and alcohol consumption
were mainly restricted to men (see Table 1), so stratifications are not presented
for women.
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fat diets so the relevance of these findings is limited. A recent
report demonstrated that the active vitamin D metabolite 1,25-
dihydroxyvitamin D3 can induce phase I and phase II metabolising
enzymes in the intestine of vitamin D-deficient rats (Kutuzova and
Deluca, 2007). This cohort is vitamin D deficient and highly
exposed to polycyclic aromatic hydrocarbons (Roth et al,
1998a,b), due to using coal for cooking and heating. The induction
of phase I metabolising genes may lead to increased activation to
reactive intermediates of these pro-carcinogens, thereby increasing
cancer risk (Shimada, 2006).
As in all observational epidemiologic studies, we cannot confirm
that the association between higher serum 25(OH)D and risk of
ESCC in men is causal and not due to confounding by other
unmeasured factors.
In conclusion, we found a direct association between higher
serum 25(OH)D concentration and increased risk of ESCC in men
but not women in a large population-based prospective cohort
study from rural China. We found no association with risk of
gastric cardia or noncardia adenocarcinoma in either sex. Greater
than 50% of our cohort had an inadequate serum 25(OH)D
concentration, yet higher concentrations were associated with
increased risk of ESCC compared to lower concentrations.
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Q1 Q2 Q3 Q4
Group HR 95% CI P Ref HR 95% CI HR 95% CI HR 95% CI Ptrend
c
ESCC
Overall
d, N cases/controls
e 545:1071 142:267 123:267 116:269 164:268
1.06 1.01–1.13 0.026 1.0 0.87 0.64–1.17 0.85 0.63–1.16 1.30 0.97–1.73 0.013
Men, N cases/controls 261:590 55:149 56:148 67:147 83:146
1.15 1.07–1.25 0.00013 1.0 1.04 0.66–1.61 1.31 0.85–2.00 1.77 1.16–2.70 0.0033
Women, N cases/controls 284:481 78:120 79:118 47:122 80:121
0.98 0.90–1.07 0.71 1.0 1.00 0.67–1.49 0.60 0.38–0.93 1.06 0.71–1.59 0.70
Gastric cardia adenocarcinoma
Overall
d, N cases/controls 353:1086 97:271 73:268 80:273 103:274
1.03 0.96–1.10 0.36 1.0 0.77 0.54–1.09 0.81 0.57–1.15 1.11 0.80–1.55 0.49
Men, N cases/controls 204:597 54:148 43:149 49:150 58:150
1.06 0.97–1.15 0.22 1.0 0.81 0.51–1.29 0.91 0.58–1.42 1.14 0.73–1.77 0.51
Women, N cases/controls 149:489 37:123 33:122 42:121 37:123
0.99 0.89–1.11 0.92 1.0 0.92 0.54–1.57 1.17 0.70–1.97 1.09 0.64–1.85 0.55
Gastric noncardia adenocarcinoma
Overall
d, N cases/controls 81:1096 22:274 10:276 23:274 26:272
0.98 0.86–1.12 0.77 1.0 0.46 0.21–0.99 0.95 0.51–1.76 1.10 0.60–2.01 0.39
Men, N cases/controls 60:601 18:150 7:153 21:149 14:149
0.94 0.80–1.09 0.40 1.0 0.40 0.16–0.98 1.17 0.60–2.29 0.80 0.38–1.67 0.87
Women, N cases/controls 21:495 4:124 5:124 6:124 6:123
1.11 0.89–1.38 0.37 1.0 1.39 0.36–5.36 1.66 0.45–6.12 1.29 0.46–3.22 0.40
Abbreviations: CI¼confidence interval; ESCC¼oesophageal squamous cell carcinomas; HR¼hazard ratio.
aHR and 95% CI in the overall models were calculated using models
stratified on age and sex with additional adjustment by separate continuous age variables for each stratum, and for cigarette smoking and alcohol drinking. Models in women were
not adjusted for smoking because o1% of women smoked cigarettes.
bContinuous HRs are scaled to 15nmoll
 1, the approximate size of one central quartile in the overall
population distribution given in Table 2.
cP for trend comes from a model where quartile of 25(OH)D status was entered as an ordinal variable.
dP for interaction between serum
vitamin D concentration (continuous variable) and sex: ESCC¼0.0065; Gastric cardia adenocarcinoma, P¼0.44; Gastric noncardia adenocarcinoma, P¼0.21.
eThis study used a
case–cohort design, therefore control numbers are slightly lower than the subcohort number presented in Table 1.
Vitamin D and oesophageal and gastric cancer
W Chen et al
127
British Journal of Cancer (2007) 97(1), 123–128 & 2007 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ystatus and cancer incidence and mortality in men. J Natl Cancer Inst 98:
451–459
Grant WB (2002) An estimate of premature cancer mortality in the US
due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:
1867–1875
Ke L (2002) Mortality and incidence trends from esophagus cancer
in selected geographic areas of China circa 1970–90. Int J Cancer 102:
271–274
Kutuzova GD, Deluca HF (2007) 1,25-Dihydroxyvitamin D3 regulates genes
responsible for detoxification in intestine. Toxicol Appl Pharmacol 218:
37–44
Launoy G, Milan C, Day NE, Pienkowski MP, Gignoux M, Faivre J (1998)
Diet and squamous-cell cancer of the oesophagus: a French multicentre
case-control study. Int J Cancer 76: 7–12
Li B, Taylor PR, Li J-Y, Dawsey SM, Wang W, Tangrea JA, Liu BQ, Ershow
AG, Zheng S-F, Fraumeni Jr JF, Yang Q, Yu Y, Sun Y, Li G, Zhang D,
Greenwald P, Lian G-T, Yang CS, Blot WJ (1993) Linxian nutrition
intervention trials. Design, methods, participant characteristics, and
compliance. Ann Epidemiol 3: 577–585
Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni Jr
JF, Blot WJ, Dong ZW, Taylor PR (2000) Prospective study of serum
selenium levels and incident esophageal and gastric cancers. J Natl
Cancer Inst 92: 1753–1763
Prentice RL (1986) A case cohort design for epidemiologic cohort studies
and disease prevention trials. Biometrika 73: 1–11
Roth MJ, Guo-Qing W, Lewin KJ, Ning L, Dawsey SM, Wesley MN, Giffen C,
Yong-Qiang X, Maher MM, Taylor PR (1998a) Histopathologic changes
seen in esophagectomy specimens from the high-risk region of
Linxian, China: potential clues to an etiologic exposure? Hum Pathol
29: 1294–1298
Roth MJ, Strickland KL, Wang GQ, Rothman N, Greenberg A, Dawsey SM
(1998b) High levels of carcinogenic polycyclic aromatic hydrocarbons
present within food from Linxian, China may contribute to that region’s
high incidence of oesophageal cancer. Eur J Cancer 34: 757–758
Self SG, Prentice RL (1988) Asymptotic distribution theory and efficiency
results for case-cohort studies. Ann Stat 16: 64–81
Shimada T (2006) Xenobiotic-metabolizing enzymes involved in activation
and detoxification of carcinogenic polycyclic aromatic hydrocarbons.
Drug Metab Pharmacokinet 21: 257–276
Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo
J, Albanes D (2006) A prospective nested case-control study of vitamin D
status and pancreatic cancer risk in male smokers. Cancer Res 66:
10213–10219
Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W,
Blot WJ, Dong ZW, Mark SD (2003) Prospective study of serum
vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst
95: 1414–1416
Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M
(2005) Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-
hydroxylase and implications for chemoprevention and treatment.
J Steroid Biochem Mol Biol 97: 103–109
Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD,
Qiao YL, Taylor PR (2004) Prospective study of risk factors for
esophageal and gastric cancers in the Linxian general population trial
cohort in China. Int J Cancer 113: 176–181
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G,
Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M,
Hakama M (2004) Both high and low levels of blood vitamin D are
associated with a higher prostate cancer risk: a longitudinal, nested case-
control study in the Nordic countries. Int J Cancer 108: 104–108
Xue L, Lipkin M, Newmark H, Wang J (1999) Influence of dietary calcium
and vitamin D on diet-induced epithelial cell hyperproliferation in mice.
J Natl Cancer Inst 91: 176–181
Zadshir A, Tareen N, Pan D, Norris K, Martins D (2005) The prevalence
of hypovitaminosis D among US adults: data from the NHANES III.
Ethn Dis 15: S5–S101
Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the
evidence? Br J Nutr 89: 552–572
Zou XN, Taylor PR, Mark SD, Chao A, Wang W, Dawsey SM, Wu YP, Qiao
YL, Zheng SF (2002) Seasonal variation of food consumption and
selected nutrient intake in Linxian, a high risk area for esophageal cancer
in China. Int J Vitam Nutr Res 72: 375–382
Vitamin D and oesophageal and gastric cancer
W Chen et al
128
British Journal of Cancer (2007) 97(1), 123–128 & 2007 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
y